Additional Capabilities for Bioassay Quantal Response

A quantal response assay models a proportion responding at each dose with a probit or logit link. This add-on adds a Validity test method setting: likelihood-ratio deviance (default) or Finney's classical minimum chi-square (the EP 5.3 default). An automatic note flags any dose group with exactly 0% or 100% response and recommends Finney's method. Potency, its confidence interval and the coefficients are unaffected.

Last reviewed

Key takeaway

The quantal response bioassay option computes the regression, parallelism and linearity validity tests by likelihood-ratio deviance or by Finney's classical minimum chi-square, which stays stable when a dose group has 0% or 100% response.

On this page
  1. Bioassay — Quantal Response Method
  2. What Was Added
  3. Regulatory and Statistical Background
  4. The Mathematics
  5. Reasoning: Why Two Conventions, and When to Use Each
  6. What Changes in the Output, and What Does Not
    1. Affected:
    2. Not affected:
  7. Where to Find This Capability
  8. Verification Against Published Reference Data
  9. References

Bioassay — Quantal Response Method

Capability added: Optional Validity Test Method ("Likelihood-Ratio Deviance" vs. "Finney's Classical Chi-Square") and Automatic Extreme-Response Diagnostic Note

 

What Was Added

The Quantal Response Method gains a second, optional way of computing its three validity tests (Significance of Regression, Parallelism, Linearity), alongside a new automatic diagnostic note that appears only when the data contains a specific condition that can make the default calculation numerically unstable. The point estimate of relative potency and its confidence interval are unaffected by either addition — both concern only the validity tests and how much users can trust them.

Regulatory and Statistical Background

A quantal response assay is used when the recorded outcome is a proportion — for example, the fraction of test subjects responding at each dose — rather than a continuous measurement. A model (commonly probit or logit) is fitted linking log-dose to response probability, and the same three validity checks as the other bioassay methods (regression significance, parallelism, linearity) are required before potency can be reported.

Two distinct, independently valid statistical procedures exist for computing those three validity tests. The modern default fits a series of nested generalised linear models by maximum likelihood and compares them via likelihood-ratio deviance tests. The classical alternative, described in full by D.J. Finney in "Statistical Method in Biological Assay" (a foundational reference this entire family of bioassay tools follows), instead uses a minimum chi-square procedure built on a linearized "working" variate. European Pharmacopoeia (Ph. Eur.), Chapter 5.3 — "Statistical Analysis of Results of Biological Assays and Tests"-compliant commercial software conventionally uses the latter.

The Mathematics

Deviance method (this tool's existing default). A fully saturated model — one free parameter for every individual preparation/dose group — is fitted by maximum likelihood, alongside progressively more restricted nested models (a common slope across preparations; a fully pooled single line). Each validity test is the likelihood-ratio deviance difference between two of these nested models:

Deviance difference = -2 x (log-likelihood of the simpler model - log-likelihood of the more general model)

which is compared to a chi-square distribution with degrees of freedom equal to the difference in the number of fitted parameters between the two models. This is the standard modern maximum-likelihood approach, but it depends on the fully saturated model converging to a finite estimate for every single group — which fails whenever a group's observed response rate is exactly 0% or exactly 100%, since no finite parameter value can reproduce that outcome under a probit or logit model (a condition statisticians call "perfect separation").

Finney's classical minimum chi-square method (the new option). Rather than fitting a saturated model, the procedure starts from the already-converged common-slope model and, for each dose group, computes a "working" probit or logit value — the fitted linear predictor adjusted by a correction term proportional to how far the observed proportion responding differs from the model's predicted proportion, weighted by the reciprocal of the binomial variance expected at that point:

working variate (per group) = fitted linear predictor + (observed proportion - fitted proportion) / (local slope of the link function)

weight (per group) = group size x (local slope of the link function)^2 / (fitted proportion x (1 - fitted proportion))

An ordinary weighted-least-squares regression and sequential analysis of variance is then run on these working variates in place of the raw proportions, giving Regression, Non-Parallelism and Non-Linearity chi-square statistics that never require any individual group's own parameter to be separately estimated — so a 0% or 100% group never causes a non-finite fit.

Reasoning: Why Two Conventions, and When to Use Each

Both methods are asymptotically equivalent for well-behaved data and, in practice, produce nearly identical chi-square statistics whenever every dose group has an observed response rate safely away from 0% or 100%. The deciding factor for which to use is therefore the data, not a matter of preference: whenever a dose group happens to show a genuinely extreme observed proportion — a common, unremarkable occurrence at the tails of a dose-response curve, especially with modest group sizes — the deviance method's validity statistics can become unstable or inflated, while Finney's method remains numerically well-behaved because it never requires that extreme group's own parameter to be fitted in isolation.

To make this actionable without requiring a user to understand the underlying numerical issue, the tool now also checks the raw data directly for this exact condition (any dose group where the number responding is exactly zero or exactly equal to the number of subjects tested) and, if found, displays an automatic note explaining the risk and recommending the Finney chi-square method — regardless of which validity method is currently selected. This detection is deliberately based on the observed proportions themselves, rather than on any numerical warning the underlying computation may or may not raise, since a broader class of technical warnings can otherwise fire even on well-behaved data with no extreme group present, which would be a false alarm.

Selecting Finney's method is recommended whenever the note appears, and is also useful for reconciling validity-test statistics with EP 5.3-compliant commercial software, which defaults to it. Where no extreme group is present, the tool's existing deviance-based default remains a fully valid, standard choice.

What Changes in the Output, and What Does Not

Affected:

  • The Chi-Square (or F-value) and P-value columns of the three validity tests (Significance of Regression, Parallelism, Linearity)
  • A new automatic diagnostic note (shown regardless of the selected method) when any dose group has an exactly 0% or 100% observed response

Not affected:

  • The estimated relative potency for each test preparation
  • The potency confidence interval
  • The fitted regression coefficients (slope and intercepts)

Where to Find This Capability

On the Quantal Response Method tool's input form, a field labelled "Validity test method" offers a choice between "Likelihood-ratio deviance (this tool's default)" and "Finney's classical minimum chi-square (EP 5.3 default)". The automatic diagnostic note, when triggered, appears in the output alongside the validity results regardless of which method is selected.

qr-add-option-bioassay


Verification Against Published Reference Data

Both additions were checked against a published worked example that Finney himself used to illustrate the method — a probit-model assay of insulin potency measured by mouse convulsion response, at nine dose levels for the standard and five for the test preparation, drawn from Finney's own textbook. The standard preparation's lowest dose group (dose 3.4, n=33) has zero responders — a genuine 0% observation, and exactly the condition the new automatic note is designed to detect.

Source: D.J. Finney, "Statistical Method in Biological Assay," 3rd Edition (1978), Griffin, London, worked example on p. 376 — as reproduced in Stegmann Systems' PLA 3.0 published example report (Document-2077, "D.J. Finney, p. 376... Insulin, Mouse convulsion - with Suitability tests")

Test / Metric

Published (Finney / PLA)

Computed (Finney chi-square option)

Significance of Regression (chi-sq, df=1)

130.26783, p=3.581E-30

130.2678, p≈0

Parallelism (chi-sq, df=1)

0.28243, p=0.59512

0.2824, p=0.5951

Linearity (chi-sq, df=10)

5.42085, p=0.86135

5.4208, p=0.8614

Potency ratio (T:S)

0.66852

0.66852 (unaffected by this setting, as expected)

95% CI

0.55339 – 0.80406

0.5534 – 0.8041 (unaffected by this setting, as expected)

 

With the default (deviance-based) method active on this same dataset, the tool's automatic diagnostic note correctly appeared, identifying the standard preparation's dose-3.4 group as the source of risk and recommending the Finney chi-square method. With the Finney chi-square method selected, the note correctly did not appear, since that method is not subject to the underlying instability. A separate check confirmed the note does not appear on well-behaved datasets containing no extreme group, ruling out false alarms.

References

  • European Pharmacopoeia (Ph. Eur.), Chapter 5.3 — "Statistical Analysis of Results of Biological Assays and Tests" (5th Edition, 2005, and successive editions).
  • United States Pharmacopeia, General Chapter <111> — "Design and Analysis of Biological Assays".
  • Finney, D.J. (1978). "Statistical Method in Biological Assay," 3rd Edition. Charles Griffin & Company, London. Worked example and data: p. 376.
  • Stegmann Systems GmbH, PLA 3.0 published worked example (Document-2077) — https://www.bioassay.de/media/document/document-2077-o130_permanent_pla_307.pdf

Frequently asked questions

What is a quantal response bioassay?

A quantal response assay is used when the recorded outcome is a proportion, such as the fraction of subjects responding at each dose, rather than a continuous measurement. A probit or logit model links log-dose to response probability, and the assay must pass validity checks for regression significance, parallelism and linearity before relative potency is reported.

Why can the deviance method fail when a dose group has 0% or 100% response?

The deviance method fits a saturated model with one parameter per dose group. When a group's observed response is exactly 0% or 100%, no finite parameter can reproduce it under a probit or logit model, a condition called perfect separation. The validity statistics can then become unstable or inflated, while Finney's method stays numerically well-behaved.

How does Finney's minimum chi-square method work?

It starts from the converged common-slope model and computes a working probit or logit value for each dose group, adjusted by how far the observed proportion differs from the fitted one, with weights based on the binomial variance. A weighted least-squares regression on these working variates gives the regression, non-parallelism and non-linearity chi-square statistics.

How do you choose the validity test method in Zometric Statistical Software?

On the Quantal Response Method input form, the Validity test method field offers Likelihood-ratio deviance (the default) or Finney's classical minimum chi-square. Select Finney's method whenever the automatic diagnostic note reports a dose group with exactly zero responders or all subjects responding, or when matching EP 5.3-compliant software.